Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01174277 · ClinicalTrials.gov registry record
Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT01174277 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 23 participants.
The verdict
NCT01174277 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
By doing this study, researchers hope to understand the many changes that occur in the blood of people who have chronic GvHD. This may also help the researcher understand how ECP works and help guide therapy for patients who have chronic GvHD in the future.
Interventions
- OTHER Collection of blood sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2010-08 |
| Est. Completion | 2016-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01174277
The ClinicalTrials.gov registry entry for NCT01174277 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collection of blood sample is the first listed.
NCT01174277 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01174277 about?
NCT01174277 is a clinical study titled "Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.". By doing this study, researchers hope to understand the many changes that occur in the blood of people who have chronic GvHD. This may also help the researcher understand how ECP works and help guide therapy for patients who have chronic GvHD in the future.
What is the current status of trial NCT01174277?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2010-08. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01174277?
The interventions under investigation include: Collection of blood sample (OTHER).
Who is sponsoring clinical trial NCT01174277?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.